Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Antonio Tapia‐Galisteo
Observed names:
Antonio Tapia-Galisteo,
Tapia Galisteo, Antonio
Institutions:
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Hospital Universitario 12 De Octubre
Observed institutions:
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Hospital Universitario 12 De Octubre,
Hospital Universitario Puerta de Hierro Majadahonda,
Hospital del Mar Research Institute
ORCID:
0000-0002-0507-8435
Observed ORCID:
0000-0002-0507-8435
OpenAlex ID:
A5091886704
Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
2023
·
Antonio Tapia-Galisteo
, Luis Álvarez-Vallina
, et al.
·
Journal of Hematology & Oncology
·
154
PDF
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
2018
·
Marta Compte
, Seandean Lykke Harwood
, et al.
·
Nature Communications
·
150
PDF
When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy
2023
·
Antonio Tapia-Galisteo
, Marta Compte
, et al.
·
Theranostics
·
111
PDF
TGF‐β‐induced IGFBP‐3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion
2020
·
Rocío Navarro
, Antonio Tapia‐Galisteo
, et al.
·
Molecular Oncology
·
39
PDF
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo
2024
·
Laura Díez-Alonso
, Aïda Falgas
, et al.
·
Science Translational Medicine
·
38
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
2022
·
Belén Blanco
, Ángel Ramírez-Fernández
, et al.
·
Cancer Immunology Research
·
34
PDF
An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2021
·
Marta Compte
, Seandean L. Harwood
, et al.
·
Clinical Cancer Research
·
30
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response
2023
·
Laura Rubio-Pérez
, Rodrigo Lázaro-Gorines
, et al.
·
OncoImmunology
·
20
Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin
2019
·
Raquel Ibáñez-Pérez
, Patricia Guerrero-Ochoa
, et al.
·
OncoImmunology
·
18
PDF
Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation
2025
·
Oana Hangiu
, Rocío Navarro
, et al.
·
Frontiers in Immunology
·
17
PDF
Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity
2022
·
Oana Hangiu
, Marta Compte
, et al.
·
iScience
·
17
PDF
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses
2024
·
Antonio Tapia-Galisteo
, Iñigo Sánchez-Rodríguez
, et al.
·
OncoImmunology
·
15
PDF
Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR
2021
·
Marta Compte
, Seandean L. Harwood
, et al.
·
Frontiers in Immunology
·
8
PDF
mRNA-engineered T lymphocytes secreting bispecific T cell engagers with therapeutic potential in solid tumors
2025
·
Ivana Zagorac
, Ángel Ramírez-Fernández
, et al.
·
Frontiers in Immunology
·
5
PDF
Cell-delivered CD3×CD19 T-cell engager by STAb-T19 cells mediates leukemia clearance with limited systemic exposure
2026
·
Laura Sanz-Ortega
, Elena Barba-Sarasúa
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
Generation and functional evaluation of bispecific T cell engaging antibodies
2025
·
Antonio Tapia-Galisteo
, Rodrigo Lázaro-Gorines
, et al.
·
Methods in cell biology
·
1
A Drug‐Gated, Modular STAb‐T Immunotherapy With External Control (Adv. Sci. 61/2026)
2026
·
Susana Luengo‐Arias
, Carmen Domínguez‐Alonso
, et al.
·
Advanced Science
PDF
A Drug‐Gated, Modular STAb‐T Immunotherapy With External Control
2026
·
Susana Luengo‐Arias
, Carmen Domínguez‐Alonso
, et al.
·
Advanced Science
PDF
Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
2023
·
Belén Blanco
, Ángel Ramírez-Fernández
, et al.
Supplementary Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
2023
·
Belén Blanco
, Ángel Ramírez-Fernández
, et al.
Supplementary Methods from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S6 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S8 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S13 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Figure S4 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Show more works
View as search
Works count:
62
Citation count:
658
H-index:
12
I10-index:
12
Year
Topic
Type